Point-of-Care/Rapid Diagnostics Market Worth 38.13 Billion USD by 2022
19 Feb, 2018, 14:30 GMT
PUNE, India, February 19, 2018 /PRNewswire/ --
According to a new market research "Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022", published by MarketsandMarkets™, the global market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 129 tables and 36 figures spread through 226 pages and in-depth TOC on "Point-of-Care/Rapid Diagnostics Market"
https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
Early buyers will receive 10% customization on this report
Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, rising preference for home healthcare across the globe, and growing government initiatives supporting the adoption of POC diagnostic products are expected to drive the demand for point-of-care diagnostic products during the study period.
Based on product, the infectious disease testing products segment is expected to register the highest growth rate during the forecast period
Based on product, the global Point-of-Care Diagnostics Market is segmented into glucose monitoring products, infectious disease testing products, coagulation testing products, cardiometabolic testing products, hematology testing products, urinalysis testing products, cholesterol testing products, drugs of abuse testing products, tumor/cancer marker testing products, pregnancy and fertility testing products, fecal occult testing products, and other POC products (multi-assay testing, liver testing, hepatitis A & B testing, and vitamin assay testing). The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the growing patient population base and increasing availability and awareness about infectious disease POC testing products.
Inquiry Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=106829185
Based on platform, lateral flow assays are estimated to be the largest segment of the market in 2017
Based on platform, the Point-of-Care Diagnostics Market is segmented into lateral flow assays, immunoassays, POC molecular diagnostics, dipsticks, and microfluidics. The lateral flow assays segment is expected to account for the largest share of the market in 2017. The large share of this segment can be attributed to the increasing prevalence of infectious diseases and growing adoption of lateral flow POC diagnostics as compared to lab tests.
Based on end user, the home care segment is expected to register the fastest growth rate in the forecast period
Based on end user, the Point-of-Care Diagnostics Market is segmented into professional diagnostic centers, home care, research laboratories, and other end users. The home care segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.
North America accounted for the largest share of the Point-Of-Care Diagnostics Market
Geographically, the Point-of-Care Diagnostics Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to account for the largest share of the market in 2017. This can be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives to support the adoption of POC in this region.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=106829185
The major players of the Point-of-Care Diagnostics Market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).
Browse Related Reports
In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021
https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets' flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets